Mezlocillin is a new semisynthetic penicillin that inhibited 71% of the isolates of Serratia marcescens, 67% of Escherichia coli, 50% of Enterobacter spp., and 49% ofKlebsiella spp. at a concentration of 12.5 ,ug/ml. It is also active against both indole-positive and -negative Proteus spp. and gram-positive cocci, except penicillin G-resistant Staphylococcus aureus. At a concentration of 100 ,mg/ml, it inhibited 94% of the isolates ofPseudomonas aeruginosa. It is more active than ampicillin, carbenicillin, and cephalothin against some gram-negative bacilli.
Gram-negative bacilli continue to be a major cause of infection in hospitalized patients. This is especially true among patients with malignant diseases and patients receiving immunosuppressive therapy (3, 4) . Often these patients do not respond, despite the in vitro susceptibility of the etiological organism to the antibiotic utilized (1) . Consequently, there is a continuing need for the development of new antibiotics. The ureido-penicillins are an interesting group of semisynthetic penicillins that have broadspectrum activity against gram-negative bacilli, including Pseudomonas aeruginosa (2) . Offe, and W. Schrock, Prog. Abstr. Intersci. Conf., Antimicrob. Agents Chemother., 14th, San Francisco, Calif., Abstr. 372, 1974 ; K. Metzger, Prog. Abstr. Intersci. Conf. Antimicrob. Agents Chemother., 15th, Washington, D.C., 332, 1975) . This report presents the results of in vitro studies of mezlocillin, which indicate that it may be a potentially useful antibiotic.
MATERIALS AND METHODS
Susceptibility tests were conducted on 556 clinical isolates of gram-negative bacilli and 88 clinical isolates of gram-positive cocci, using the dilution technique with an automatic microtiter system (Canalco, Autotiter instruction manual). All organisms were inoculated into Mueller-Hinton broth (Difco) and incubated at 37°C for 18 h. For gram-negative bacilli, a 0.05-ml sample of a 10-3 dilution of this broth culture (approximately 105 colony-forming units [CFU]/ml) was used as the inoculum. For gram-positive cocci, a 0.05-ml sample of a 10-2 dilution of this broth culture (approximately 106 CFU/ ml) was used as the inoculum for susceptibility testing.
All gram-negative bacilli used in this study were cultured from blood specimens obtained from patients between 1967 and 1975. The patients were hospitalized at this institution and had underlying malignant diseases. A total of 100 isolates each ofP. aeruginosa, Klebsiella spp., and Escherichia coli, 98 isolates ofProteus spp., 69 broth, and the minimal inhibitory concentration (MIC) was determined after incubation at 37°C for 18 h. All wells containing trace growth or no discernible growth were subcultured on sheep blood agar. A calibrated pipette was used to transfer 0.01 ml of the inoculum. The minimum bactericidal concentration (MBC) was determined after incubation at 37C for 18 h. The MBC was defined as the lowest concentration of drug that yielded less than 50 colonies on subculture (less than 5 colonies/0.001 ml of inoculum). Comparison studies were conducted simultaneously.
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RESULTS
The in vitro activity of mezlocillin against gram-positive cocci and gram-negative bacilli is shown in Fig. 2 . Although the majority of isolates of S. pneumoniae were quite susceptible to mezlocillin, 14% required concentrations of 6.25 to 25 ,ug/ml to inhibit their growth. Likewise, the majority of penicillin G-susceptible S. aureus were inhibited by 0.20 ug or less of mezlocillin per ml, whereas penicillin G-resistant S. aureus were also resistant to mezlocillin. Isolates ofS. pyogenes were quite susceptible to mezlocillin. Over 95% of the isolates ofP. mirabilis and 70% of the isolates of indole-positive Proteus spp. were susceptible to 1.56 u.g or less of mezlocillin per ml. A concentration of 12. 5 ,ug/ml inhibited 71% of the isolates of S. marcescens, 67% of E. coli, 50%o of Enterobacter spp., and 49% ofKlebsiella spp., but only 27% of P. aeruginosa. However, at a concentration of 100 ,g/ml, mezlocillin inhibited 94% of the isolates ofP. aeruginosa. Generally, the ANTIMICROB. AGENTS CHEMOTHER. isolates ofE. coli, the MIC and MBC were the same. Inoculum size had the greatest effect on the activity of mezlocillin against K. pneumoniae. Using an inoculum of 105 CFU/ml, all isolates were inhibited at a concentration of 6.25 zg/ml, whereas using an inoculum of 107 CFU/ml, none was inhibited at a concentration of 400 jg/ml. The MIC and MBC for isolates of E. coli increased sixfold or more when the inoculum size was increased from 105 to 107 CFU/ ml. All of the isolates of P. aeruginosa were inhibited by 100 ug or less of mezlocillin per ml when the inoculum was 105 CFU/ml, but only 30% were inhibited by 400 pAg/ml when the inoculum was 107 CFU/ml.
The effect of pH on the susceptibility of 10 isolates each ofE. coli, K. pneumoniae, and P. aeruginosa is shown in Fig. 4 . The pH was adjusted by the addition of phosphate buffer to Mueller-Hinton broth. The greatest effect was observed against isolates ofE. coli, which were more susceptible at alkaline pH. The pH had no appreciable effect on the activity of mezlocillin against isolates of P. aeruginosa. Media had little effect on the activity of mezlocillin (Fig.  5) and P. aeruginosa were slightly more resistant when tested in nutrient broth, with the exception of one isolate ofE. coli which was considerably more susceptible to mezlocillin when tested in nutrient broth.
The activity of mezlocillin against 50 isolates each of various gram-negative bacilli was compared with ampicillin, carbenicillin, and cephalothin (Fig. 6 to 10) . Figure 10 shows similar data for 21 isolates of indole-positive Proteus spp. Mezlocillin was the most active drug against isolates ofE. coli, although about 30% of the isolates were resistant to 25 ,ug/ml and some of these isolates were more susceptible to cephalothin. Cephalothin was the most active antibiotic against K. pneumoniae, although mezlocillin was the most active penicillin. Mez (Fig.  11) . The most active antibiotic was BL-P1654 and the least active was carbenicillin. Mezlocillin and ticarcillin had comparable activity. DISCUSSION Mezlocillin is a broad-spectrum semisynthetic penicillin with activity against both gram-positive cocci and gram-negative bacilli. It is of particular interest because it is marginally active against S. marcescens, K. pneumoniae, and P. aeruginosa. It is more active in vitro than ampicillin or carbenicillin againstE. coli and as active as these two penicillins against P. mirabilis. It is also more active in vitro than carbenicillin against indole-positive Proteus spp. and Enterobacter spp. It is as active as cephalothin against 80% of the isolates (5, 6) . Mezlocillin is an interesting new penicillin because of its broad-spectrum activity. The drug deserves further evaluation because it is potentially more active than ampicillin, carbenicillin, and cephalothin against some gramnegative bacilli. ACKNOWLEDGMENTS This work was supported by Public Health Service grant CA-10042 from the National Cancer Institute and a grantin-aid from Delbay Pharmaceuticals, Inc., Bloomfield, N.J.
